Who owns SONNET BIOTHERAPEUTC HLDNG I?

Tip: Access positions for across all investors

Analyze quarterly positions in Sonnet Biotherapeutc Hldng I with up to 7 years of data, all consolidated into one spreadsheet

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Top investors of Sonnet Biotherapeutc Hldng I stock

Who bought or sold SONNET BIOTHERAPEUTC HLDNG I this quarter?

Fund or Company Name Shares Held Valued At Change in Shares As Of Actions
BBK Capital Partners 37k $170k 100% Dec 2025
 View chart

Who sold out of Sonnet Biotherapeutc Hldng I?

Fund or Company Name Date Sold Shares Held Valued At
Ikarian Capital Sep 2025 150k $687k
Vanguard Group Sep 2025 96k $441k
Hrt Financial Sep 2025 74k $340k
Geode Capital Management Sep 2025 62k $283k
Boothbay Fund Management Sep 2025 56k $258k
Goldman Sachs Group Sep 2025 55k $253k
Citadel Advisors Sep 2025 46k $211k